BioSpace News Archive

Better Choice Company today announced that the Company will participate in the LD Micro Main Event and the Dawson James Small Cap Growth Conference in October 2021.

Berkeley Lights, Inc. announced Genovac’s expansion into cell line development capabilities using the Berkeley Lights Beacon® system and Opto™ CLD workflow.

Skye Bioscience, Inc. has appointed Kaitlyn Arsenault, CPA, as Chief Financial Officer.

Cintex Services, LLC and Senores Pharmaceuticals, Inc. announce the launch of Chlorzoxazone Tablets USP, 250 mg, a therapeutic equivalent version of Paraflex (Chlorzoxazone) 250 mg in the U.S. market.

Since the emergence of SARS-CoV-2, public health laboratories and researchers have been developing surveillance methods using wastewater to control the spread of COVID-19.

Emerge Diagnostics, a HealthTech firm specializing in soft tissue injury management, today announced enhancements to its breakthrough Electrodiagnostic Functional Assessment (EFA) programs, which will make it possible to deliver comprehensive functional assessments and objective Independent Medical Exams (IMEs) remotely via telemedicine.

RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) (“RegeneRx”), a clinical-stage drug development company focused on tissue protection, repair and regeneration), today announced that a new research paper was published demonstrating Thymosin Beta 4’s (Tβ4) positive effects on animal models related to Alzheimer’s Disease.

Scopus BioPharma Inc. (Nasdaq: “SCPS”), today announced it will be presenting at the LD Micro Main Event, which is being held in-person and virtually from October 12th through 14th, 2021.

EmphyCorp Inc. www.EmphyCorp.com, a private corporation, specializes in Rx Non-Steroidal Nasal Spray Technology.

TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage cell therapy company with a pipeline of novel T cell therapies for patients suffering from cancer, today announced the e-poster presentation of new preclinical data at the American Association for Cancer Research (AACR) Virtual Special Conference on Tumor Immunology and Immunotherapy, taking place October 5-6, 2021.